Wu_2003_CNS.Drugs_17_1045

Reference

Title : The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach - Wu_2003_CNS.Drugs_17_1045
Author(s) : Wu G , Lanctot KL , Herrmann N , Moosa S , Oh PI
Ref : CNS Drugs , 17 :1045 , 2003
Abstract : Wu_2003_CNS.Drugs_17_1045
ESTHER : Wu_2003_CNS.Drugs_17_1045
PubMedSearch : Wu_2003_CNS.Drugs_17_1045
PubMedID: 14594444

Related information

Citations formats

Wu G, Lanctot KL, Herrmann N, Moosa S, Oh PI (2003)
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach
CNS Drugs 17 :1045

Wu G, Lanctot KL, Herrmann N, Moosa S, Oh PI (2003)
CNS Drugs 17 :1045